or
forgot password

Personal Patient Profile Prostate (P4) Randomized, Multisite Trial


N/A
21 Years
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Personal Patient Profile Prostate (P4) Randomized, Multisite Trial


Inclusion Criteria:



- Biopsy-proven diagnosis of prostate cancer, stage I or II

- Diagnosis within the past 6 months

- Has appointment with a consulting specialist at one of the clinical trial sites

- Must be able to read and write English or Spanish at a 6th grade level

- Must not have begun any treatment (except watchful waiting)

- Must be able to complete baseline assessment before target clinician visit.

Exclusion Criteria:

- Advanced prostate cancer

- Diagnosed more than 6 months ago

- Cannot read and write English or Spanish at a 6th grade level

- Does not have appointment at one of the clinical trial sites

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Outcome Measure:

Decisional Conflict

Outcome Time Frame:

Baseline to 6 months

Safety Issue:

No

Principal Investigator

Seth Wolpin, RN, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Washington

Authority:

United States: Federal Government

Study ID:

1 R01 NR009692

NCT ID:

NCT00692653

Start Date:

February 2007

Completion Date:

December 2009

Related Keywords:

  • Prostate Cancer
  • Localized prostate cancer
  • Treatment decision making
  • Tailored decision aid
  • Prostatic Neoplasms

Name

Location
Fox Chase Cancer Center Philadelphia, Pennsylvania  19111
University of Washington Medical Center Seattle, Washington  98195-6043
University of Texas Health Sciences Center at San Antonio San Antonio, Texas  78229
Veterans Administration Puget Sound Health Care System Seattle, Washington  98108-1597
Seattle Prostate Institute Seattle, Washington  98104
VA Medical Center / Medical College of Georgia Augusta, Georgia  30904